EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

A novel multiplex and glycoprotein-based immunochromatographic serologic IgM test for the rapid diagnosis of Escherichia coli O157 and O145 causing bloody diarrhea and hemolytic uremic syndrome

Stella M Landivar, Luciano J Melli, Cynthia Maiztegui, Carla Schesi, Ariela Baschkier, Valeria Francisetti, Isabel Chinen, Elizabeth Miliwebsky, Marta Rivas, Diego J Comerci, Juan E Ugalde iD, Andrés E Ciocchini iD

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.01003-24 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Stella M Landivar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín (UNSAM)-Consejo Nacional de Investigaciones Científicas y Técnicas (…. Hauptthemen laut MEDLINE: Immunoglobulin M, Hemolytic-Uremic Syndrome, Escherichia coli Infections, Diarrhea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shiga toxin-producing Escherichia coli (STEC) are the main etiological agents of hemolytic uremic syndrome (HUS). Good clinical management of STEC infections and HUS depends on early, rapid, and accurate diagnosis. Here, we have developed and evaluated the first multiplex and glycoprotein-based immunochromatographic test for the detection of IgM antibodies against the O-polysaccharide of the lipopolysaccharide of E. coli O157 and O145 in human serum samples. A retrospective study was carried out resulting in a diagnostic sensitivity of the E. coli O157/O145 LFIA (lateral flow immunoassay) of 97.1% and 98.9% for O157 and O145, respectively, and 97.9% for both serogroups. The diagnostic specificity was 98.7% for O157 and O145, and the overall specificity 97.4%. In samples obtained before 3 days after the onset of diarrhea, the detection percentage was 83%, increasing to 100% from 3 days onward. Finally, the association of bloody diarrhea (BD) or HUS cases to an STEC infection increased from 22.8% to 77.2% when stool culture and stx /Stx detection were combined with serology by LFIA. Our results demonstrate that the E. coli O157/O145 LFIA is a highly accurate and serospecific test for the early and rapid diagnosis of E. coli O157 and O145 infections in BD or HUS cases. This test allows the detection of specific IgM antibodies very early in the course of the infection, making it an ideal diagnostic tool to be implemented in pediatric emergencies and, thus, avoid delays in the application of the correct supportive or specific treatment and prevent complications associated with HUS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin MHemolytic-Uremic SyndromeEscherichia coli InfectionsDiarrheaSensitivity and SpecificityAntibodies, BacterialHumansRetrospective StudiesChild, PreschoolFemaleMaleInfantO AntigensChromatography, AffinityChildAdultAdolescentMiddle AgedSerologic TestsEscherichia coli O157Shiga-Toxigenic Escherichia coliYoung AdultAged

Stichwörter der Autor:innen

HUSIgMSTECdiagnosticglycoproteinimmunochromatographylateral flowmultiplexquickserodiagnosis

Substanzen

Immunoglobulin MAntibodies, BacterialO Antigens

Autor:innen und Institutionen

  • Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín (UNSAM)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Escuela de Bio y Nanotecnologías (EByN), Universidad Naciona…
  • Chemtest Argentina S. A., San Martín, Buenos Aires, Argentina.
  • Laboratorio Nacional de Referencia, Servicio Fisiopatogenia, Instituto Nacional de Enfermedades Infecciosas-ANLIS Dr. Carlos G. Malbrán, Ciudad Autónoma de Buenos Aires, Argentina.
  • Laboratorio Central de la Provincia de Córdoba, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
  • Inmunova S. A., San Martin, Buenos Aires, Argentina.

ORCID-Profile: Juan E Ugalde, Andrés E Ciocchini

Zitieren

APA

Landivar, S. M., Melli, L. J., Maiztegui, C., Schesi, C., Baschkier, A., Francisetti, V., Chinen, I., Miliwebsky, E., Rivas, M., Comerci, D. J., Ugalde, J. E., & Ciocchini, A. E. (2024). A novel multiplex and glycoprotein-based immunochromatographic serologic IgM test for the rapid diagnosis of Escherichia coli O157 and O145 causing bloody diarrhea and hemolytic uremic syndrome. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01003-24

Vancouver

Landivar SM, Melli LJ, Maiztegui C, Schesi C, Baschkier A, Francisetti V, et al. A novel multiplex and glycoprotein-based immunochromatographic serologic IgM test for the rapid diagnosis of Escherichia coli O157 and O145 causing bloody diarrhea and hemolytic uremic syndrome. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.01003-24

BibTeX
@article{Landivar2024,
  author = {Landivar, Stella M and Melli, Luciano J and Maiztegui, Cynthia and Schesi, Carla and Baschkier, Ariela and Francisetti, Valeria and Chinen, Isabel and Miliwebsky, Elizabeth and Rivas, Marta and Comerci, Diego J and Ugalde, Juan E and Ciocchini, Andrés E},
  title = {A novel multiplex and glycoprotein-based immunochromatographic serologic IgM test for the rapid diagnosis of Escherichia coli O157 and O145 causing bloody diarrhea and hemolytic uremic syndrome},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.01003-24}
}
Kostenlos starten →